XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 104 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,193,186 | -46.9% | 641,498 | -25.3% | 0.01% | -55.6% |
| Q2 2023 | $2,249,037 | +143608.4% | 858,411 | -10.6% | 0.03% | +12.5% |
| Q1 2023 | $1,565 | +22.6% | 960,111 | 0.0% | 0.02% | -4.0% |
| Q4 2022 | $1,277 | -99.9% | 960,111 | 0.0% | 0.02% | -21.9% |
| Q3 2022 | $1,498,000 | +1.3% | 960,111 | 0.0% | 0.03% | -17.9% |
| Q2 2022 | $1,479,000 | -39.9% | 960,111 | -0.1% | 0.04% | -32.8% |
| Q1 2022 | $2,461,000 | -12.5% | 961,192 | +0.1% | 0.06% | +23.4% |
| Q4 2021 | $2,813,000 | – | 960,111 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 6,039,028 | $15,460,000 | 19.22% |
| Stonepine Capital Management, LLC | 7,924,056 | $20,286,000 | 8.41% |
| ARMISTICE CAPITAL, LLC | 7,464,993 | $19,110,000 | 0.37% |
| NEA Management Company, LLC | 3,246,785 | $8,312,000 | 0.24% |
| Alpine Global Management, LLC | 633,040 | $1,620,000 | 0.20% |
| DELTEC ASSET MANAGEMENT LLC | 248,000 | $635,000 | 0.11% |
| Redmile Group, LLC | 1,046,587 | $2,679,000 | 0.08% |
| CTC Capital Management, LLC | 11,800 | $30,000 | 0.08% |
| TUDOR INVESTMENT CORP ET AL | 961,192 | $2,461,000 | 0.06% |
| Yakira Capital Management, Inc. | 117,076 | $300,000 | 0.04% |